1. Sclerostin aggravates insulin signaling in skeletal muscle and hepatic steatosis via upregulation of ER stress by mTOR‐mediated inhibition of autophagy under hyperlipidemic conditions
   Heeseung Oh et al, 2022, Journal of Cellular Physiology CrossRef
2. Similarities and Differences: A Comparative Review of the Molecular Mechanisms and Effectors of NAFLD and AFLD
   Pengyi Zhang et al, 2021, Frontiers in Physiology CrossRef
3. The pivotal role of dysregulated autophagy in the progression of non-alcoholic fatty liver disease
   Qiaohui Shen et al, 2024, Frontiers in Endocrinology CrossRef
4. Anti‐b diminishes hyperlipidaemia and hepatic steatosis in hamsters and mice by suppressing the mTOR/PPARγ and mTOR/SREBP1 signalling pathways
   Yu Bian et al, 2024, British Journal of Pharmacology CrossRef